CLINICAL_TRIALS
trial_result
· 2021-05-18
Clinical Trial Update: Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia [Phase 3]
Summary
Phase 3 trial updates on the efficacy and safety of evinacumab in patients with Homozygous Familial Hypercholesterolemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2021-05-18